ReP USP - Resultado da busca

Filtros : "Financiamento FAPESP" "IDPC" Removido: "ICB" Limpar

Filtros

USP affiliated authors
- barroso, lucia pereira (1)
- bertolami, adriana (1)
- erger, inar castro (1)
- farsky, pedro silvio (1)
- farsky, sandra helena poliselli (1)

Artigo de periodico
GPCRs overexpression and impaired fMLP-induced functions in neutrophils from chronic kidney disease patients (2024)
Scharf, Pablo Rhasan dos Santos ; Sandri, Silvana ; Rizzetto, Felipe; Xavier, Luana Filippi; Grosso, Daniela; Silva, Rebeca D. Correia; Farsky, Pedro Silvio; Gil, Cristiane D; Farsky, Sandra Helena Poliselli
Source: Frontiers in Immunology. Unidades: IDPC, FCF
Subjects: NEFROPATIAS, NEUTRÓFILOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHARF, Pablo Rhasan dos Santos et al. GPCRs overexpression and impaired fMLP-induced functions in neutrophils from chronic kidney disease patients. Frontiers in Immunology, v. 15, n. p. 13 art. 1387566, 2024Tradução . . Disponível em: https://dx.doi.org/10.3389/fimmu.2024.1387566. Acesso em: 08 out. 2025.
APA
Scharf, P. R. dos S., Sandri, S., Rizzetto, F., Xavier, L. F., Grosso, D., Silva, R. D. C., et al. (2024). GPCRs overexpression and impaired fMLP-induced functions in neutrophils from chronic kidney disease patients. Frontiers in Immunology, 15( p. 13 art. 1387566). doi:10.3389/fimmu.2024.1387566
NLM
Scharf PR dos S, Sandri S, Rizzetto F, Xavier LF, Grosso D, Silva RDC, Farsky PS, Gil CD, Farsky SHP. GPCRs overexpression and impaired fMLP-induced functions in neutrophils from chronic kidney disease patients [Internet]. Frontiers in Immunology. 2024 ; 15( p. 13 art. 1387566):[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.3389/fimmu.2024.1387566
Vancouver
Scharf PR dos S, Sandri S, Rizzetto F, Xavier LF, Grosso D, Silva RDC, Farsky PS, Gil CD, Farsky SHP. GPCRs overexpression and impaired fMLP-induced functions in neutrophils from chronic kidney disease patients [Internet]. Frontiers in Immunology. 2024 ; 15( p. 13 art. 1387566):[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.3389/fimmu.2024.1387566
Artigo de periodico
Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease? (2023)
Pimentel, Mariana Vieira de Mello Barros; Bertolami, Adriana; Fernandes, Lígia Prestes; Barroso, Lucia Pereira; Castro, Inar Alves de
Source: Biomedicine and Pharmacotherapy. Unidades: IDPC, IME, FCF
Subjects: BIOMARCADORES, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, Mariana Vieira de Mello Barros et al. Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease?. Biomedicine and Pharmacotherapy, v. 160, p. 1-12 art. 114345, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2023.114345. Acesso em: 08 out. 2025.
APA
Pimentel, M. V. de M. B., Bertolami, A., Fernandes, L. P., Barroso, L. P., & Castro, I. A. de. (2023). Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease? Biomedicine and Pharmacotherapy, 160, 1-12 art. 114345. doi:10.1016/j.biopha.2023.114345
NLM
Pimentel MV de MB, Bertolami A, Fernandes LP, Barroso LP, Castro IA de. Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease? [Internet]. Biomedicine and Pharmacotherapy. 2023 ; 160 1-12 art. 114345.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.biopha.2023.114345
Vancouver
Pimentel MV de MB, Bertolami A, Fernandes LP, Barroso LP, Castro IA de. Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease? [Internet]. Biomedicine and Pharmacotherapy. 2023 ; 160 1-12 art. 114345.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.biopha.2023.114345

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2025